Follow
Diana M. Leite
Diana M. Leite
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia
SD Santos, M Xavier, DM Leite, DA Moreira, B Custódio, M Torrado, ...
Journal of controlled release 291, 65-79, 2018
762018
Peptide self-assemblies for drug delivery
D M Leite, E Barbu, G J Pilkington, A Lalatsa
Current Topics in Medicinal Chemistry 15 (22), 2277-2289, 2015
642015
On the shuttling across the blood-brain barrier via tubules formation: mechanism and cargo avidity bias
X Tian, DM Leite, E Scarpa, S Nyberg, G Fullstone, J Forth, DL Matias, ...
Science Advances 6 (48), eabc4397, 2020
552020
A human co‐culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics
DM Leite, BZ Baskovic, P Civita, C Neto, M Gumbleton, GJ Pilkington
FASEB Journal 34 (1), 1710-1727, 2020
532020
Pre-clinical drug testing in 2D and 3D human in vitro models of glioblastoma incorporating non-neoplastic astrocytes: Tunneling nano tubules and mitochondrial transfer …
P Civita, DM Leite, GJ Pilkington
International Journal of Molecular Sciences 20 (23), 2019
472019
Designing peptide nanoparticles for efficient brain delivery
A Duro-Castano, DM Leite, J Forth, Y Deng, D Matias, CN Jesus, ...
Advanced Drug Delivery Reviews 160, 52-77, 2020
362020
The role of BAR proteins and the glycocalyx in brain endothelium transcytosis
DM Leite, D Matias, G Battaglia
Cells 9 (12), 2685, 2020
102020
Combinatorial intracellular delivery screening of anticancer drugs
B Sola-Barrado, DM Leite, E Scarpa, A Duro-Castano, G Battaglia
Molecular Pharmaceutics 17 (12), 4709-4714, 2020
92020
Nanotechnology in brain tumor targeting: Efficacy and safety of nanoenabled carriers undergoing clinical testing
A Lalatsa, DM Leite, MF Figueiredo, M O’Connor
Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, 111-145, 2018
92018
Nanomedicines and the future of glioma
A Lalatsa, DM Leite, GJ Pilkington
Oncology News 10 (2), 51-57, 2015
52015
Exploring poly(ethylene glycol)-poly(trimethylene carbonate) nanoparticles as carriers of hydrophobic drugs to modulate osteoblastic activity
DM Leite, DM Sousa, M Lamghari, AP Pêgo
Journal of Pharmaceutical Sciences, 2020
42020
Nanomedicines and the future of glioma
DM Leite, G Pilkington, K Lalatsa
Oncology News 10 (2), 16-21, 2015
42015
Syndapin-2 mediated transcytosis of amyloid-β across the blood–brain barrier
D M. Leite, M Seifi, L Ruiz-Perez, F Nguemo, M Plomann, JD Swinny, ...
Brain Communications 4 (1), fcac039, 2022
32022
Single-domain antibodies for brain targeting
K Lalatsa, DM Leite
BioPharm International 27 (8), 20-26, 2014
32014
Peptide nanofibers
A Lalatsa, D LEITE
12019
Structural Biology in the Liquid State: Shedding Light on Protein Dynamics
L Ruiz-Pérez, G Ing, S Acosta-Gutierrez, C De Pace, G Marchello, D Leite, ...
Microscopy and Microanalysis 28 (S1), 2250-2250, 2022
2022
Imaging Protein Dynamics in Liquid Water
C De Pace, S Acosta-Gutierrez, G Ing, G Marchello, S Pilotto, F Werner, ...
Microscopy and Microanalysis 27 (S2), 15-16, 2021
2021
Liquid-Phase Electron Microscopy in Structural Protein Studies
G Ing, C De Pace, SA Guitierrez, G Marchello, S Pilotto, D Leite, ...
Microscopy and Microanalysis 27 (S2), 89-90, 2021
2021
Peptide nanofibers
A Lalatsa, D Leite
US Patent App. 17/045,085, 2021
2021
The role of syndapin-2 mediated transcytosis across the blood-brain barrier on amyloid-β accumulation in the brain
DM Leite, M Seifi, L Ruiz-Perez, F Nguemo, M Plomann, JD Swinny, ...
bioRxiv, 2020.07. 12.199869, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20